Skip to Main Content

Paper Details

SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency.
medRxiv
2
2021
SARS-CoV, SARS-CoV-2
Author NameAffiliation
Michael P BuschUniversity of California san francisco
Michael P BuschVitalant Research Institute
Jeffrey N MartinUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Timothy J HenrichUniversity of California san francisco
  • 1 - 6

Datasets

Release 1.2